Filing Details

Accession Number:
0001628280-25-005864
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-14 18:41:53
Reporting Period:
2025-02-13
Filing Date:
2025-02-14
Accepted Time:
2025-02-14 18:41:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1706431 Vir Biotechnology Inc. VIR Biological Products, (No Disgnostic Substances) (2836) 812730369
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2037272 Brent Sabatini C/O Vir Biotechnology, Inc.
1800 Owens Street, Suite 900
San Francisco CA 94158
Svp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-13 1,562 $9.15 28,189 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
  2. Reflects ownership after acquisition by the reporting person on November 29, 2024 of 1,312 shares of common stock pursuant to the Issuer's employee stock purchase program.